Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes

5Citations
Citations of this article
102Readers
Mendeley users who have this article in their library.

Abstract

There is a large body of pre-clinical and some clinical data to link the neuropeptide galanin to a range of physiological and pathological functions that include metabolism, depression, and addiction. An enhancer region upstream of the human GAL transcriptional start site has previously been characterised. In-vitro transfection studies in rat hypothalamic neurons demonstrated that the CA allele was 40% less active than the GG allele in driving galanin expression. Our hypothesis was to investigate the effect of this galanin enhancer genotype on a range of variables that relate to the known functions of the galaninergic system in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort of young adults (N=169-6,078). Initial findings showed a positive relationship of cannabis usage (OR=2.070, P=0.007, N=406 (individuals who had used cannabis at least once within the last 12 months, total sample size 2731) with the GG haplotype, consistent with the previous published data linking galanin with an increased release of dopamine. As our sample size was relatively small we replicated the analysis in a larger cohort of 2,224 African Americans and 1,840 European Americans, but no discernible trend across genotypes was observed for the relationship with cannabis usage. Further, we found no association of the galanin enhancer genotype with any of the other pathophysiological parameters measured. These findings emphasise that preclinical data does not always predict clinical outcomes in cohort studies, noting that association studies are subject to multiple confounders.

References Powered by Scopus

PLINK: A tool set for whole-genome association and population-based linkage analyses

24286Citations
N/AReaders
Get full text

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC- IV): Description, differences from previous versions, and reliability of some common diagnoses

2966Citations
N/AReaders
Get full text

Cohort profile: The 'Children of the 90s'-The index offspring of the avon longitudinal study of parents and children

2098Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin

41Citations
N/AReaders
Get full text

A Review of Single-Nucleotide Polymorphisms in Orexigenic Neuropeptides Targeting G Protein-Coupled Receptors

14Citations
N/AReaders
Get full text

Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neurones

14Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Richardson, T. G., Minica, C., Heron, J., Tavare, J., Mackenzie, A., Day, I., … Wynick, D. (2014). Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 165(8), 654–664. https://doi.org/10.1002/ajmg.b.32270

Readers over time

‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2507142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 36

63%

Researcher 15

26%

Professor / Associate Prof. 4

7%

Lecturer / Post doc 2

4%

Readers' Discipline

Tooltip

Psychology 23

43%

Medicine and Dentistry 12

23%

Biochemistry, Genetics and Molecular Bi... 10

19%

Social Sciences 8

15%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 23

Save time finding and organizing research with Mendeley

Sign up for free
0